Hypercoagulability in various autoimmune diseases: No association with factor V Leiden mutation

Haematologia

Volumn 30, Issue 1, 2000, Pages 35-39

  Regeczy N ^a,b   Balogh, I ^a   Lakos, G ^a   Zeher, M ^a   Bodolay, E ^a   Szucs G ^a   Kiss, E ^a   Ajzner, E ^a   Szegedi, G ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b National Institute of Haematology and Immunology Budapest   (Hungary)

Author keywords

Antiphospholipid antibody; Autoimmune disease; Leiden mutation; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PHOSPHOLIPID ANTIBODY;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RISK FACTOR; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; POLYMERASE CHAIN REACTION; RISK FACTORS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0033644736     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: 10.1163/15685590051129869     Document Type: Article

References (13)

1. Rees, D. C., Cox, M., Clegg, J. B., World distribution of factor V Leiden, Lancet 346 (8983), 1133 (1995).
2. Herrmann, F. H., Koesling, M., Schroder, W., Altman, R., Jimenez-Bonilla, R., Lopaciuk, S., Perez-Requejo, J. L., Singh, J. R., Prevalence of factor V Leiden mutation in various populations, Genet. Epidemiol. 14 (4), 403 (1997).
3. Póka, R., Ajzner, É., Balogh, I., Public health approach to activated protein C resistance assay, Am. J. Obstet. Gynecol. 177 (5), 1271 (1997) (Letter).
4. Tordai, A., Klein, I., Rajczy, K., Pénzes, M., Sarkadi, B., Váradi, A., Prevalence of factor V Leiden (Arg 506 Gln) in Hungary, Br. J. Haematol. 99, 466 (1997).
5. Price, D. T., Ridker, P. M., Factor V Leiden mutation and the risks for thromboembolic disease: clinical perspective, Ann. Intern. Med. 127 (10), 895 (1997).
6. Sasso, E. H., Suzuki, L. A., Thompson, A. R., Petri, M. A., Hereditary resistance to activated protein C: an uncommon risk factor for thromboembolic disease in lupus patients with antiphospholipid antibodies, Arthritis Rheum. 40 (9), 1720 (1997).
7. De Lucia, D., De Blasio, G., Belli, A. et al., High prevalence of activated protein C resistance in patients with systemic sclerosis, Int. J. Clin. Lab. Res. 25 (4), 226 (1995) (Letter).
8. Fijnheer, R., Horbach, D. A., Donders, R. C., Factor V Leiden, antiphospholipid antibodies and thrombosis in lupus erythematosus, Thromb. Haemost. 76, 514 (1996).
9. Matsuda, J., Gohchi, K., Tsukamoto, M., Gotoh, M., Saitoh, N., Kawasugi, K., Resistance to activated protein C in systemic lupus erythematosus with antiphospholipid antibodies, Eur. J. Haematol. 53 (3), 188 (1994).
10. Bengston, A., Zoller, B., de Frutos, P. G., Dahlbäck, B., Sturfelt, G., Factor V:Q 506 mutation and anticardiolipin antibodies in systemic lupus erythematosus, Lupus 5 (6), 698 (1996).
11. Bertina, R. M., Koeleman, B. P. C., Koster, T. et al., Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature 369, 64 (1994).
12. Svensson, P. J., Dahlbäck, B., Resistance to activated protein C as a basis for venous thrombosis. N. Engl. J. Med. 330, 517 (1994).
13. Dizon-Townson, D., Hutchinson, C., Silver, R., Branch, D. W., Ward, K., The Factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome, Thromb. Haemost. 74 (4), 1029 (1995).